ImmunoGenes produces monoclonal and polyclonal antibodies using our IMG-AbS™ platform technology. This patented technology allows us to produce high quality and diverse antibodies against challenging antigens. IMG-AbS™ is redefining the parameters of antibody production by offering highly customized antibodies that are difficult or impossible to generate using standard methods.
Our patented technology allows us to produce high quality and diverse antibodies against the most challenging antigens. We specialize in highly customized antibody production. Our in-house scientists will collaborate with you to develop a custom solution to fit your protocol. Learn More
ImmunoGenes' offers a variety of customized transgenic solutions in a number of different animal models, including mice and rabbits, by microinjecting large genomic fragments at its state-of-the-art facility. Learn More